On Thursday, March 28th, BTL Aesthetic will be presenting a one year review of the HIFEM technology and EMSCULPT Body Contouring at a special evening event at ASLMS 2019 in Denver Colorado.
The presentation will feature the following thought leaders:
- Barry DiBernardo, MD - Plastic Surgeon
- Brian Kinney, MD - Plastic Surgeon
- Bruce Katz, MD - Dermatologist
- Carolyn Jacob, MD - Dermatologist
- David Kent, MD - Dermatologist
- Minni Saluja, MD - Ophthalmologist/Dermatologic Cosmetic Surgeon
- Richard Goldfarb, MD - Cosmetic Surgeon
- Robert Weiss, MD - Dermatologist
- Suneel Chilukuri, MD - Dermatologist
- Yael Halaas, MD - Dermatologist
New Applications will be announced.
Seating is limited, please register ASAP to reserve your place: http://ahb.cc/btl-aslms
BTL released a statement today:
BTL, leaders in non-invasive aesthetics, today announced that eight studies have been accepted for presentation at the 39th Annual Conference of the American Society for Laser Medicine & Surgery (ASLMS) taking place March 27th – 31st. Having transformed the body shaping category with its launch of EMSCULPT last year and with the acceptance of numerous studies for presentation during the elite conference, BTL further solidifies its position as a leader in aesthetic innovation.
Continuing the momentum of EMSCULPT, the brand will take its strengthening and toning capabilities to new areas of the body with the release of its small applicator. Up until now, there were only FDA cleared protocols for the abdominals and buttocks. With the addition of the small applicator, EMSCULPT is now cleared for strengthening, firming and toning of arms and thighs, further expanding the device's versatility for physicians, adding additional revenue opportunities and patient's satisfaction. Similar to abdominal and buttocks therapies, unique protocols have been developed for the treatment of the arms, thighs, and calves.
"We at BTL are always researching new innovations and raising the bar in aesthetics in order to improve patient satisfaction and outcomes," shared John Ferris, Vice President of US Marketing at BTL. "We're looking forward to sharing our latest findings with the esteemed attendees of ASLMS and being the driving force behind the ongoing evolution of the category," added John Ferris.
In addition to launching the small applicator, BTL will also highlight new clinical findings demonstrating long term EMSCULPT results with six-month and one-year data. Research will also be unveiled showcasing the impressive results for the new applications. Additionally, the brand will celebrate their physician supporters and the impact of EMSCULPT with an exclusive event Thursday evening.
---------- end of BTL statement ----------
Thursday March 28, 2019
Hyatt Regency Denver
Centennial Ballroom F-H